Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Fig. 2

Mean laboratory parameters over time in the total population. Mean neutrophil count (a); lymphocyte count (b); platelet count (c); haemoglobin (d); serum creatinine (e); low-density lipoprotein cholesterol (LDL-c) (f); high-density lipoprotein cholesterol (HDL-c) (g); and total cholesterol (h). Baseline values were those of the phase II or phase III index study. SE standard error

Back to article page